Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St rebounds after Fed's first rate hike in years as oil, Treasury yields dip
- Oil falls 2% to one-week low as Middle East supply disruption fears ease
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Paradium AI (PAAI) Halted, News Pending
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Hims & Hers Health, Inc. (HIMS) Reports Q4 Loss of $0.07 on Revenues of $41.7M; Offers 1Q & FY21 Revenues Guidance
March 18, 2021 4:10 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reported Q4 EPS of ($0.07), versus ($0.16) reported last year. Revenue for the quarter came in at $41.47 million, versus $41.32 million reported last year.
We closed out this important year for Hims & Hers on a high note, meeting or exceeding the expectations for 2020 performance in our roadshow this past fall, including 80% revenue growth year-over-year and improved gross margins, said Andrew Dudum, CEO and co-founder of Hims & Hers. We also made smart... More
